Analyst Ratings for Iterum Therapeutics (ITRM)

ITRM Rating Summary

  |   Expand Research on ITRM
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/4/2026 Maxim Group Jason McCarthy Downgrade Hold
(Buy)		 N/A
(N/A)		 0.15
(0.17)		 13.33% Details
5/8/2025 H.C. Wainwright Matthew Keller New Coverage Buy
(N/A)		 9.00
(N/A)		 0.92
(0.17)		 -81.52% Details